Nida Zahra Naqvi, MD | |
500 Upper Chesapeake Dr, Bel Air, MD 21014 | |
(443) 643-1500 | |
(443) 643-1505 |
Full Name | Nida Zahra Naqvi |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 10 Years |
Location | 500 Upper Chesapeake Dr, Bel Air, Maryland |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104211168 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | D0085227 (Maryland) | Secondary |
207Q00000X | Family Medicine | D0085227 (Maryland) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Umd Upper Chesapeake Medical Center | Bel air, MD | Hospital |
University Of Md Harford Memorial Hospital | Havre de grace, MD | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Adfinitas Health At Upper Chesapeake Harford Memorial Llc | 5799141388 | 44 |
Adfinitas Health At Upper Chesapeake Llc | 6305202540 | 80 |
News Archive
Stem cell scientists from around the world gathered at the International Society of Stem Cell Research (ISSCR) in San Francisco to exchange information about the latest treatments with stem cells. An American company, TCA Cellular Therapy, LLC announced its FDA clinical trial results using adult stem cells in patients with history of a heart attack during open heart surgery.
Risky behaviors such as not using condoms or having sex with multiple people put young adults at risk for contracting sexually transmitted diseases, but perhaps not as much as the characteristics of their sexual partners, University of Florida researchers say.
The National Institutes of Health has awarded scientists at Albert Einstein College of Medicine of Yeshiva University a five-year, $3.9 million grant to study how extensively drug-resistant tuberculosis is transmitted in rural South Africa. The findings could alter public health approaches for controlling the XDR-TB epidemic in the developing world.
Spherix Incorporated – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today reported the successful completion of its 28-day rat toxicology study of its drug candidate, SPX-106.
Colon cancer is the second most common cancer in the United States and causes more than 50,000 deaths each year. It has been known for some time that mutations in the APC gene occur in more than 85 percent of all sporadic colon cancers. Now researchers at Huntsman Cancer Institute at the University of Utah demonstrate in a study featured today in Cell the mechanism by which mutation of the APC gene affects a cellular process known as DNA methylation.
› Verified 4 days ago
Entity Name | Upper Chesapeake Medical Services Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1497801419 PECOS PAC ID: 3173556974 Enrollment ID: O20050913000525 |
News Archive
Stem cell scientists from around the world gathered at the International Society of Stem Cell Research (ISSCR) in San Francisco to exchange information about the latest treatments with stem cells. An American company, TCA Cellular Therapy, LLC announced its FDA clinical trial results using adult stem cells in patients with history of a heart attack during open heart surgery.
Risky behaviors such as not using condoms or having sex with multiple people put young adults at risk for contracting sexually transmitted diseases, but perhaps not as much as the characteristics of their sexual partners, University of Florida researchers say.
The National Institutes of Health has awarded scientists at Albert Einstein College of Medicine of Yeshiva University a five-year, $3.9 million grant to study how extensively drug-resistant tuberculosis is transmitted in rural South Africa. The findings could alter public health approaches for controlling the XDR-TB epidemic in the developing world.
Spherix Incorporated – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today reported the successful completion of its 28-day rat toxicology study of its drug candidate, SPX-106.
Colon cancer is the second most common cancer in the United States and causes more than 50,000 deaths each year. It has been known for some time that mutations in the APC gene occur in more than 85 percent of all sporadic colon cancers. Now researchers at Huntsman Cancer Institute at the University of Utah demonstrate in a study featured today in Cell the mechanism by which mutation of the APC gene affects a cellular process known as DNA methylation.
› Verified 4 days ago
Entity Name | Adfinitas Health At Upper Chesapeake Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1164134037 PECOS PAC ID: 6305202540 Enrollment ID: O20230515001078 |
News Archive
Stem cell scientists from around the world gathered at the International Society of Stem Cell Research (ISSCR) in San Francisco to exchange information about the latest treatments with stem cells. An American company, TCA Cellular Therapy, LLC announced its FDA clinical trial results using adult stem cells in patients with history of a heart attack during open heart surgery.
Risky behaviors such as not using condoms or having sex with multiple people put young adults at risk for contracting sexually transmitted diseases, but perhaps not as much as the characteristics of their sexual partners, University of Florida researchers say.
The National Institutes of Health has awarded scientists at Albert Einstein College of Medicine of Yeshiva University a five-year, $3.9 million grant to study how extensively drug-resistant tuberculosis is transmitted in rural South Africa. The findings could alter public health approaches for controlling the XDR-TB epidemic in the developing world.
Spherix Incorporated – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today reported the successful completion of its 28-day rat toxicology study of its drug candidate, SPX-106.
Colon cancer is the second most common cancer in the United States and causes more than 50,000 deaths each year. It has been known for some time that mutations in the APC gene occur in more than 85 percent of all sporadic colon cancers. Now researchers at Huntsman Cancer Institute at the University of Utah demonstrate in a study featured today in Cell the mechanism by which mutation of the APC gene affects a cellular process known as DNA methylation.
› Verified 4 days ago
Entity Name | Adfinitas Health At Upper Chesapeake Harford Memorial Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457051724 PECOS PAC ID: 5799141388 Enrollment ID: O20230524002364 |
News Archive
Stem cell scientists from around the world gathered at the International Society of Stem Cell Research (ISSCR) in San Francisco to exchange information about the latest treatments with stem cells. An American company, TCA Cellular Therapy, LLC announced its FDA clinical trial results using adult stem cells in patients with history of a heart attack during open heart surgery.
Risky behaviors such as not using condoms or having sex with multiple people put young adults at risk for contracting sexually transmitted diseases, but perhaps not as much as the characteristics of their sexual partners, University of Florida researchers say.
The National Institutes of Health has awarded scientists at Albert Einstein College of Medicine of Yeshiva University a five-year, $3.9 million grant to study how extensively drug-resistant tuberculosis is transmitted in rural South Africa. The findings could alter public health approaches for controlling the XDR-TB epidemic in the developing world.
Spherix Incorporated – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today reported the successful completion of its 28-day rat toxicology study of its drug candidate, SPX-106.
Colon cancer is the second most common cancer in the United States and causes more than 50,000 deaths each year. It has been known for some time that mutations in the APC gene occur in more than 85 percent of all sporadic colon cancers. Now researchers at Huntsman Cancer Institute at the University of Utah demonstrate in a study featured today in Cell the mechanism by which mutation of the APC gene affects a cellular process known as DNA methylation.
› Verified 4 days ago
Entity Name | Adfinitas Health At Upper Chesapeake Aberdeen Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346941010 PECOS PAC ID: 8022475581 Enrollment ID: O20230530000304 |
News Archive
Stem cell scientists from around the world gathered at the International Society of Stem Cell Research (ISSCR) in San Francisco to exchange information about the latest treatments with stem cells. An American company, TCA Cellular Therapy, LLC announced its FDA clinical trial results using adult stem cells in patients with history of a heart attack during open heart surgery.
Risky behaviors such as not using condoms or having sex with multiple people put young adults at risk for contracting sexually transmitted diseases, but perhaps not as much as the characteristics of their sexual partners, University of Florida researchers say.
The National Institutes of Health has awarded scientists at Albert Einstein College of Medicine of Yeshiva University a five-year, $3.9 million grant to study how extensively drug-resistant tuberculosis is transmitted in rural South Africa. The findings could alter public health approaches for controlling the XDR-TB epidemic in the developing world.
Spherix Incorporated – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today reported the successful completion of its 28-day rat toxicology study of its drug candidate, SPX-106.
Colon cancer is the second most common cancer in the United States and causes more than 50,000 deaths each year. It has been known for some time that mutations in the APC gene occur in more than 85 percent of all sporadic colon cancers. Now researchers at Huntsman Cancer Institute at the University of Utah demonstrate in a study featured today in Cell the mechanism by which mutation of the APC gene affects a cellular process known as DNA methylation.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Nida Zahra Naqvi, MD 500 Upper Chesapeake Dr, Bel Air, MD 21014-4324 Ph: (443) 643-1500 | Nida Zahra Naqvi, MD 500 Upper Chesapeake Dr, Bel Air, MD 21014 Ph: (443) 643-1500 |
News Archive
Stem cell scientists from around the world gathered at the International Society of Stem Cell Research (ISSCR) in San Francisco to exchange information about the latest treatments with stem cells. An American company, TCA Cellular Therapy, LLC announced its FDA clinical trial results using adult stem cells in patients with history of a heart attack during open heart surgery.
Risky behaviors such as not using condoms or having sex with multiple people put young adults at risk for contracting sexually transmitted diseases, but perhaps not as much as the characteristics of their sexual partners, University of Florida researchers say.
The National Institutes of Health has awarded scientists at Albert Einstein College of Medicine of Yeshiva University a five-year, $3.9 million grant to study how extensively drug-resistant tuberculosis is transmitted in rural South Africa. The findings could alter public health approaches for controlling the XDR-TB epidemic in the developing world.
Spherix Incorporated – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today reported the successful completion of its 28-day rat toxicology study of its drug candidate, SPX-106.
Colon cancer is the second most common cancer in the United States and causes more than 50,000 deaths each year. It has been known for some time that mutations in the APC gene occur in more than 85 percent of all sporadic colon cancers. Now researchers at Huntsman Cancer Institute at the University of Utah demonstrate in a study featured today in Cell the mechanism by which mutation of the APC gene affects a cellular process known as DNA methylation.
› Verified 4 days ago
Dr. Shilpi Khosla, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 615 W Macphail Rd, Ste 106, Bel Air, MD 21014 Phone: 410-638-8900 Fax: 410-638-8915 | |
Dr. Maureen C Sullivan, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12 Medstar Blvd, Bel Air, MD 21015 Phone: 410-807-8088 Fax: 410-807-8170 | |
Kelsey Schwartz Chmielewski, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 615 W Macphail Rd Ste 106, Bel Air, MD 21014 Phone: 410-638-8900 | |
Dr. James E. Lacey, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 560 W Macphail Rd, Bel Air, MD 21014 Phone: 410-638-6480 | |
Bhagya J. Pallerla, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 560 W Macphail Rd, Bel Air, MD 21014 Phone: 410-638-6480 | |
Dr. Robert Duncan, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 615 W Macphail Rd, Ste 106, Bel Air, MD 21014 Phone: 410-638-8900 Fax: 410-638-8915 | |
Sanjay Sood, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 104 Plumtree Rd Ste 115, Bel Air, MD 21015 Phone: 410-515-4300 Fax: 410-601-1052 |